Exhibit 99.1




In accordance with Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named as a prospective director of Big Cypress Acquisition Corp. (which will be renamed SAB Biotherapeutics, Inc. after the business combination) in the Registration Statement on Form S-4 filed by Big Cypress Acquisition Corp. with the Securities and Exchange Commission.


/s/ Edward Sullivan  
Name: Edward Sullivan  
Date: July 2, 2021  


/s/ Christine Hamilton  
Name: Christine Hamilton  
Date: July 2, 2021  


/s/ William Polvino  
Name: William Polvino  
Date: July 2, 2021  


/s/ Mervyn Turner  
Name: Mervyn Turner  
Date: July 2, 2021  


/s/ David Link  
Name: David Link  
Date: July 2, 2021